Selim Bolukbasi_SCIENTIFIC POSTER 2015

We present a case of retinitis pigmentosa (RP) releated cystoid macular edema that was treated with a single intravitreal injection of dexamethasone 0.7 mg implant (Ozurdex) for her both eyes. Before this treatment she was treated with oral acetolazamid, intravitreal and subtenon depot triamcinolone, but the efficacy of these treatments were limited. 21-year-old female with RP presented with complaints of bilateral decrease in visual acuity. Her best-corrected visual acuity (BCVA) was 0.1 (Snellen) in her both eyes. Biomicroscopy of the anterior segment revealed mild subcapsular cataract in her both eyes. Two months after the injections, best corrected visual acuity (BCVA) improved from 0.1 to 0.3 in her both eyes and mean central retinal thickness decreased from 588 µm to 296 µm in the left eye and 494 µm to 281 µm in the right eye. 5 months after the injections BCVA was 0.3 in her both eyes and mean central retinal thickness was 333 µm in the left eye and 318 µm in the right eye. During the follow-up there was no aggravation of the subcapsular cataract and intraocular pressure was between 11 and 17 mmHg in both eyes. Intravitreal dexamethasone implant provides anatomic and functional improvements and may be beneficial in patients with macular edema secondary to retinitis pigmentosa.

Contact Details:

Cell Phone: +905327007939